Hemodiyaliz Uygulanan Hastalarda Kemoterapi

Authors : Metin Sarikaya, Mustafa Yildirim, Funda Sari

Pages : 1-5

View : 44 | Download : 41

Publication Date : 2013-03-01

Article Type : Other

Abstract :Treatment of malignancy in patients with chronic renal failure has been an issue of debate since mid 1970’s. Any stage of chronic renal disease is seen in patients with malignancy with a high frequency such as 50-60%. Nowadays, incidence of end-stage renal failure is increasing worldwide and the majority of these patients undergo hemodialysis. Doses of the cytotoxic treatment and application of the drugs with appropriate timing according to the hemodialysis periods is important in these patients because of the side effects and efficacy of the treatment; when there is a coexisting malignancy. In this paper, tolerance and dose arrangement of the chemotheraupetics used in treatment of solid tumors in patient with end stage renal failure who undergo hemodialysis have been reviewed with current litearure
Keywords : hemodialysis, cancer, chemotherapy